The global life science market is projected to grow from USD 100.88 billion in 2025 to approximately USD 278.40 billion by 2034, reflecting a robust CAGR of 11.94%. Key factors driving this growth include the rising prevalence of chronic diseases, advancements in biotechnology and genomic research, and an increasing demand for personalized medicine.
North America currently holds the largest market share at 40.10%, while Asia Pacific is anticipated to be the fastest-growing region through 2034. Notably, biotechnology remains the leading segment, with drug discovery and oncology dominating applications and therapeutic areas, respectively. The integration of AI and big data is poised to revolutionize areas like drug development and diagnostics, despite challenges such as high R&D costs and regulatory complexities.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.biospace.com/press-releases/life-science-market-size-worth-usd-278-40-billion-by-2034
